NewAmsterdam Pharma NAMS
NASDAQ NAMS
$19.71 -1.87 (-8.67%)
At close: Oct 23, 2026 · 4:00 PM EDT

NewAmsterdam Pharma (NAMS) Purchase of Investments (2025 - 2026)

Updated

Analysis

NewAmsterdam Pharma (NAMS) Purchase of Investments (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 NewAmsterdam Pharma 2.32 Bn -290.23 Mn - 51.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.18 Mn
Mar 31, 2026 62.47 Mn
Dec 31, 2025 71.54 Mn
Sep 30, 2025 31.85 Mn
Jun 30, 2025 183.71 Mn
Mar 31, 2025 9.63 Mn
API Access

NewAmsterdam Pharma Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=NAMS&period=max&api_key=YOUR_API_KEY